Alopecia UK has now formally merged with Autoimmune Alopecia Research UK, becoming the largest alopecia charity within the UK. The merger was confirmed last month, after months of legal reviews and talks which begun in the spring.
Alopecia merger results in new branding, but same strong legacy
The trustees of both Alopecia UK and Autoimmune Alopecia Research UK (AAR-UK), decided it would be best to diminish AAR-UK and operate solely under the Alopecia UK brand. They felt it was the best name to represent the combined charity moving forward.
Whilst the name may be the same, the charity will be rolling out completely fresh branding, starting with a new logo. According to the charity, the creation of the logo was a long, difficult process. They wanted it to reflect the legacy of both brands, while also incorporating a positive element.
The result is a striking, dandelion-inspired logo, which the charity hopes will resonate with those suffering from alopecia. The dandelion element was chosen due to its link to loss, and within the logo it does have some of its florets missing.
The colour of the logo remains largely blue, synonymous with Alopecia UK’s favoured colour scheme. However, to reflect the merger, one of the dandelion’s florets is a bright, fuchsia pink, the colour AAR-UK preferred to use.
Now the logo has been completed, the charity is working on a brand-new website and new branding for its marketing materials.
What will the merger mean for alopecia sufferers?
The new branding may be exciting for the freshly merged charity, but what does it mean for alopecia sufferers? Well, along with a brand-new look, Alopecia UK is putting together a completely new research committee.
Simon Ray will chair the new committee which will be made up of the existing trustees from Alopecia UK and AAR-UK. There is also going to be a second research committee, which Karen Green will be responsible for, the former member of AAR-UK. The latter committee will be dedicated to researching more about the numerous phenotypes of alopecia in the hope of eventually finding a cure. They will especially be focusing on finding a treatment and cure for the more severe types of alopecia including Alopecia Universalis and Alopecia Totalis.
As part of the agreement for the merger, Alopecia UK promised to match the reserve budget brought from AAR-UK. This means the new research committees have double the budget to spend on research, providing hope for an eventual cure.
Few options currently available for alopecia sufferers
Whilst milder forms of alopecia can often be successfully managed, there is no cure for more severe types of the condition. This is especially true when it comes to treating children with alopecia.
Therefore, the new merger is going to prove extremely beneficial to those suffering with the more serious forms of the condition. Studies and trials carried out abroad are also proving promising for alopecia sufferers. JAK Inhibitors have shown to be particularly effective at treating baldness, with work currently underway to assess the safety of such treatments. It may take a while, but the research already underway and now the two new research committees for Alopecia UK, are sure to bring us one step closer to a possible cure.